The PCV13 vaccine makes it easier for the immune system to attack S. pneumoniae and produce antibodies by linking the polysaccharide capsule layer to proteins. Exposure to neonatal antibiotics ...

Babies treated with antibiotics in the first few weeks of their life are likely to show weaker immune responses to essential ...

Widespread use of PCV13, which covers additional serotypes 3, 6A and 19A, may contribute to reduce the clonal spread of drug-resistant 19A pneumococci. The author has no relevant affiliations or ...